Fingerprint
Dive into the research topics of 'C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R. Mc Causland, Brian Claggett, Emmanuel A. Burdmann, Kai Uwe Eckardt, Reshma Kewalramani, Andrew S. Levey, John J V McMurray, Patrick Parfrey, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert D. Toto, Marc A. Pfeffer
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations